Loading...
Innoviva reported strong royalty revenue growth of 10% year-over-year. Net income per share exceeded $1, supported by a recently completed equity repurchase.
Royalty revenues grew 10% year over year.
RELVAR®/BREO® ELLIPTA® global net sales decreased 15%.
TRELEGY® ELLIPTA® global net sales increased 77%.
Basic net income per share exceeded $1 for the quarter.
The press release contains forward-looking statements regarding goals, plans, objectives and future events, which are subject to risks, uncertainties, and assumptions.
Analyze how earnings announcements historically affect stock price performance